Annual Shareholders Equity
$113.53 M
+$226.49 M+200.51%
December 31, 2023
Summary
- As of February 26, 2025, LXEO annual stockholders equity is $113.53 million, with the most recent change of +$226.49 million (+200.51%) on December 31, 2023.
- During the last 3 years, LXEO annual shareholders equity has risen by +$119.07 million (+2150.70%).
- LXEO annual shareholders equity is now at all-time high.
Performance
LXEO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$139.33 M
-$25.62 M-15.53%
September 30, 2024
Summary
- As of February 26, 2025, LXEO quarterly stockholders equity is $139.33 million, with the most recent change of -$25.62 million (-15.53%) on September 30, 2024.
- Over the past year, LXEO quarterly shareholders equity has stayed the same.
- LXEO quarterly shareholders equity is now -23.84% below its all-time high of $182.95 million, reached on March 31, 2024.
Performance
LXEO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
LXEO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +200.5% | 0.0% |
| 3 y3 years | +2150.7% | 0.0% |
| 5 y5 years | +2150.7% | 0.0% |
LXEO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +200.5% | -23.8% | +185.6% |
| 5 y | 5-year | at high | +200.5% | -23.8% | +185.6% |
| alltime | all time | at high | +200.5% | -23.8% | +185.6% |
Lexeo Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $139.33 M(-15.5%) |
| Jun 2024 | - | $164.95 M(-9.8%) |
| Mar 2024 | - | $182.95 M(+61.1%) |
| Dec 2023 | $113.53 M | $113.53 M(-169.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | -$162.81 M(+13.4%) |
| Jun 2023 | - | -$143.62 M(+27.1%) |
| Dec 2022 | -$112.95 M(+103.1%) | -$112.95 M |
| Dec 2021 | -$55.60 M(+904.3%) | - |
| Dec 2020 | -$5.54 M | - |
FAQ
- What is Lexeo Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Lexeo Therapeutics?
- What is Lexeo Therapeutics annual shareholders equity year-on-year change?
- What is Lexeo Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Lexeo Therapeutics?
- What is Lexeo Therapeutics quarterly shareholders equity year-on-year change?
What is Lexeo Therapeutics annual stockholders equity?
The current annual shareholders equity of LXEO is $113.53 M
What is the all time high annual shareholders equity for Lexeo Therapeutics?
Lexeo Therapeutics all-time high annual stockholders equity is $113.53 M
What is Lexeo Therapeutics annual shareholders equity year-on-year change?
Over the past year, LXEO annual stockholders equity has changed by +$226.49 M (+200.51%)
What is Lexeo Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of LXEO is $139.33 M
What is the all time high quarterly shareholders equity for Lexeo Therapeutics?
Lexeo Therapeutics all-time high quarterly stockholders equity is $182.95 M
What is Lexeo Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, LXEO quarterly stockholders equity has changed by $0.00 (0.00%)